Corcept Therapeutics Inc (CORT) stock
CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30349% above fair value
$72.94−0.77 (-1.04%)
Close on Nov 13, 2026Market cap $7.88BP/E 173.7Yield –
Corcept Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Corcept Therapeutics's total assets was $888.70M at Jun 30, 2026. For fiscal 2025 it was $836.65M, down 0.5% from the year before. Over ten years it grew 32.0% a year on average. The highest annual figure on record is $840.55M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $836.65M | -0.5% |
| FY2024 | Dec 31, 2024 | $840.55M | +35.2% |
| FY2023 | Dec 31, 2023 | $621.52M | +6.5% |
| FY2022 | Dec 31, 2022 | $583.43M | +37.7% |
| FY2021 | Dec 31, 2021 | $423.76M | -25.9% |
| FY2020 | Dec 31, 2020 | $571.73M | +38.7% |
| FY2019 | Dec 31, 2019 | $412.31M | +32.3% |
| FY2018 | Dec 31, 2018 | $311.69M | +41.3% |
| FY2017 | Dec 31, 2017 | $220.54M | +220.8% |
| FY2016 | Dec 31, 2016 | $68.75M | +32.5% |
| FY2015 | Dec 31, 2015 | $51.90M | +49.9% |
| FY2014 | Dec 31, 2014 | $34.63M | -45.1% |
| FY2013 | Dec 31, 2013 | $63.08M | -36.4% |
| FY2012 | Dec 31, 2012 | $99.17M | +149.0% |
| FY2011 | Dec 31, 2011 | $39.83M | +58.7% |
| FY2010 | Dec 31, 2010 | $25.10M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $888.70M | +10.8% |
| Q1 FY2026 | Mar 31, 2026 | $814.88M | -3.7% |
| Q4 FY2025 | Dec 31, 2025 | $836.65M | -0.5% |
| Q3 FY2025 | Sep 30, 2025 | $823.61M | +5.0% |
| Q2 FY2025 | Jun 30, 2025 | $801.72M | +12.2% |
| Q1 FY2025 | Mar 31, 2025 | $846.46M | +29.0% |
| Q4 FY2024 | Dec 31, 2024 | $840.55M | +35.2% |
| Q3 FY2024 | Sep 30, 2024 | $784.26M | +32.0% |
| Q2 FY2024 | Jun 30, 2024 | $714.56M | +36.2% |
| Q1 FY2024 | Mar 31, 2024 | $655.94M | +6.2% |
| Q4 FY2023 | Dec 31, 2023 | $621.52M | +6.5% |
| Q3 FY2023 | Sep 30, 2023 | $594.02M | +11.4% |
| Q2 FY2023 | Jun 30, 2023 | $524.63M | +5.7% |
| Q1 FY2023 | Mar 31, 2023 | $617.85M | +32.0% |
| Q4 FY2022 | Dec 31, 2022 | $583.43M | +37.7% |
| Q3 FY2022 | Sep 30, 2022 | $533.26M | -8.9% |
| Q2 FY2022 | Jun 30, 2022 | $496.36M | -12.7% |
| Q1 FY2022 | Mar 31, 2022 | $468.12M | -15.3% |
| Q4 FY2021 | Dec 31, 2021 | $423.76M | -25.9% |
| Q3 FY2021 | Sep 30, 2021 | $585.40M | +9.6% |
| Q2 FY2021 | Jun 30, 2021 | $568.48M | +14.2% |
| Q1 FY2021 | Mar 31, 2021 | $552.40M | +24.0% |
| Q4 FY2020 | Dec 31, 2020 | $571.73M | +38.7% |
| Q3 FY2020 | Sep 30, 2020 | $534.13M | +45.5% |
| Q2 FY2020 | Jun 30, 2020 | $497.82M | +51.5% |
| Q1 FY2020 | Mar 31, 2020 | $445.49M | +39.1% |
| Q4 FY2019 | Dec 31, 2019 | $412.31M | +32.3% |
| Q3 FY2019 | Sep 30, 2019 | $367.02M | +22.4% |
| Q2 FY2019 | Jun 30, 2019 | $328.68M | +19.8% |
| Q1 FY2019 | Mar 31, 2019 | $320.21M | +31.8% |
| Q4 FY2018 | Dec 31, 2018 | $311.69M | +41.3% |
| Q3 FY2018 | Sep 30, 2018 | $299.75M | +170.8% |
| Q2 FY2018 | Jun 30, 2018 | $274.38M | +217.1% |
| Q1 FY2018 | Mar 31, 2018 | $242.98M | +222.5% |
| Q4 FY2017 | Dec 31, 2017 | $220.54M | +220.8% |
| Q3 FY2017 | Sep 30, 2017 | $110.67M | +75.9% |
| Q2 FY2017 | Jun 30, 2017 | $86.54M | – |
| Q1 FY2017 | Mar 31, 2017 | $75.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $68.75M | – |
| Q3 FY2016 | Sep 30, 2016 | $62.93M | – |
See a number that looks wrong?